40
Participants
Start Date
April 1, 2025
Primary Completion Date
April 1, 2025
Study Completion Date
December 31, 2025
Implanon NXT® subdermal implant
"Each implant contains 68 mg of etonogestrel. The release rate is approximately 60-70 mcg/day in the 5th-6th week and reduces to approximately 35-45 mcg/day at the end of the first year; 30-40 mcg/day at the end of the second year and 25-30 mcg/day at the end of the third year.~It will be evaluation before, 3, 6, 9 and 12 months after implant insertion.Participants' use of the device will be evaluated for one year"
Etonogestrel 68mg implant
"Each implant contains 68 mg of etonogestrel. The release rate is approximately 60-70 mcg/day in the 5th-6th week and reduces to approximately 35-45 mcg/day at the end of the first year; 30-40 mcg/day at the end of the second year and 25-30 mcg/day at the end of the third year.~It will be evaluation before, 3, 6, 9 and 12 months after implant insertion.Participants' use of the device will be evaluated for one year"
Department of Gynecology of Federal University of São Paulo, São Paulo
Collaborators (1)
Organon
INDUSTRY
Maíta Poli de Araújo
OTHER